Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026), Mineola
Laura and Isaac Perlmutter Cancer Center ( Site 5016), New York
Memorial Sloan Kettering Cancer Center ( Site 5002), New York

Набиране на участнициФаза 1/2

Възраст от 18 до 120 · Всички полове · Обновено на 2.10.2026 г. · NCT07049926

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center, New York

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 2.10.2026 г. · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли

Възраст от 40 до 75 · Всички полове · Обновено на 2.10.2026 г. · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #60, New York
Exelixis Clinical Site #6, New York
Exelixis Clinical Site #76, Syracuse

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 1.10.2026 г. · NCT05176483

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Roswell Park Comprehensive, Buffalo

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 1.10.2026 г. · NCT05287945

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
и още 3

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 30.09.2026 г. · NCT03866382

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NYU Langone Medical Center, New York

Набиране на участнициНаблюдателно проучване

Възраст 18 и повече · Всички полове · Обновено на 25.09.2026 г. · NCT04981119

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Memorial Sloan Kettering Cancer Center ( Site 0126), New York

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 25.09.2026 г. · NCT07489495

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Memorial Sloan Kettering Cancer Center, New York

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 23.09.2026 г. · NCT07293351

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Columbia University Irving Medical Center, New York

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 22.09.2026 г. · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Northwell Health Imbert Cancer Center, Bay Shore
Memorial Sloan Kettering Commack, Commack
Glens Falls Hospital, Glens Falls
и още 10

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 18.09.2026 г. · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

New York Oncology Hematology, P.C., Albany
New York Oncology Hematology - Clifton Park Cancer Center, Clifton Park
MSK Commack, Commack
и още 7

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 17.09.2026 г. · NCT07227415

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 15.09.2026 г. · NCT07195916

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
Columbia University, New York

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 14.09.2026 г. · NCT04977453

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Roswell Park Cancer Institute, Buffalo
Hematology Oncology Associates of CNY at Camillus, Camillus
Memorial Sloan Kettering Commack, Commack
и още 13

Набиране на участнициФаза 3

Възраст 18 и повече · Всички полове · Обновено на 2.09.2026 г. · NCT06661720

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и още 1

Набиране на участници

Възраст 18 и повече · Всички полове · Обновено на 2.09.2026 г. · NCT05837767

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

New York Cancer & Blood Specialists, New York
University of Rochester - Wilmot Cancer Institute, Rochester

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 27.08.2026 г. · NCT06582017

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

Roswell Park Comprehensive Cancer Center, Buffalo

Набиране на участници

Възраст 18 и повече · Всички полове · Обновено на 20.08.2026 г. · NCT07714018

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 11.08.2026 г. · NCT06242470

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Memorial Sloan Kettering Cancer Center, New York

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 11.08.2026 г. · NCT07195682

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, New York
Xencor Investigative Site, New York

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 3.08.2026 г. · NCT05433142

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

NYU Langone Health Perlmutter Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University - The Trustees of Columbia University in the City of New York, New York
и още 2

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 9.07.2026 г. · NCT03972657

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
и още 1

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 24.06.2026 г. · NCT06835972

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York

Набиране на участнициФаза 1

Възраст 18 и повече · Всички полове · Обновено на 4.06.2026 г. · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Northwell Health, Lake Success

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 28.04.2026 г. · NCT06413680

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

UB/ Great Lakes Cancer Care, Buffalo

Набиране на участнициФаза 1/2

Възраст 18 и повече · Всички полове · Обновено на 1.04.2026 г. · NCT06222593

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
и още 1

Набиране на участнициФаза 2

Възраст 18 и повече · Всички полове · Обновено на 4.03.2026 г. · NCT06699602